Vitamin D May Facilitate Prevent Diabetes, Depending on Your Genes New analysis of a major clinical trial shows that vitamin D supplementation may reduce the risk of developing type 2 diabetes in prediabetic adults—but only in those with specific genetic variations in the vitamin D receptor gene. The findings, published in JAMA Network Open on April 23, 2026, suggest a path toward more personalized prevention strategies for the over 115 million U.S. Adults living with prediabetes. Researchers from the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University re-examined data from the D2d study, a large, multi-site clinical trial that tested 4,000 international units of vitamin D daily versus placebo in more than 2,000 U.S. Adults with prediabetes. While the original trial did not present a significant reduction in diabetes risk across all participants, this new genetic subgroup analysis revealed a meaningful benefit for some. Prediabetic adults with certain variations in the vitamin D receptor gene had a 19% lower risk of developing diabetes when taking high-dose vitamin D supplements compared to those receiving a placebo. According to Bess Dawson-Hughes, M75, the study’s lead author and a senior scientist at Tufts, this finding raises the possibility that vitamin D could still benefit specific individuals even when broad population results are negative. “Diabetes has so many serious complications that develop slowly over years,” Dawson-Hughes said. “If we can delay the time period that an individual will spend living with diabetes, we can stop some of those harmful side effects or lessen their severity.” The study highlights the importance of genetic factors in nutrient response and supports the growing field of precision nutrition. More than two in five U.S. Adults have prediabetes, a condition marked by elevated blood sugar levels that often progresses to type 2 diabetes. Identifying who is most likely to benefit from interventions like vitamin D supplementation could help target prevention efforts more effectively. While the results are promising, researchers emphasize that vitamin D is not a guaranteed preventive measure for everyone. The effect appears to depend on an individual’s genetic makeup, particularly variations in genes that regulate how the body uses vitamin D. Further research is needed to determine which specific gene variants are most influential and whether routine genetic testing could one day guide supplementation advice. For now, the findings reinforce the value of discussing individual risk factors and potential preventive strategies with a healthcare provider. As science moves toward more tailored approaches, understanding how genes interact with nutrients like vitamin D may play a key role in delaying or preventing chronic diseases such as type 2 diabetes.
52